Research engineers immune-evasive islet replacement to improve graft success in type 1 diabetes, indicating potential for better treatments.
Islet transplantation offers a physiological approach to restoring endogenous insulin secretion in type 1 diabetes, yet its broad clinical application remains constrained by donor scarcity, immune-mediated rejection, and limited graft...
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: